PRA IC List
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
Information Collection List
IC Title
Status
Responses
Hours
Dollars
Document Type
Form No.
Form Name
Biosimilars Prescribing Survey
New
500
210
0
Other-Survey Instrument
Other-Screening Questions
Other-Informed Consent
Biosimilars Prescribing Survey
New
500
210
0
Other-Screening Questions
Other-Consent Form
Other-Survey Instrument
Educating Groups Influencing Generic Drug Use
New
327
137
0
Other-Recruitment Email
Other-Verbal Consents
Other-Consent Forms for Surveys
Other-Protocol for Formulary Managers
Other-Protocol for Large Purchasers
Other-Protocol for Policymakers
Other-Protocol for Prescribers
Other-Protocol for Pharmacists
Other-Protocol for Patients and Caregivers
Endorsement in Direct-to-Consumer Promotion: Cognitive Interviews
New
50
24
0
Other-Discussion Guides
Other-Interview Screener
Other-Consent Form - Study 1
Other-Consent Form - Study 2
Other-Example of Reminder Email
Formative Research Study to Understand the Impact of Generic Substitutes for Various Patient and Caregiver Populations
New
200
300
0
Other-Youth Screener
Other-Parental Permission Form
Other-Adult Screener
Other-Confirmation and Reminder Emails
Other-Adult Consent Form
Other-Youth Assent Form
Other-Worksheet
Other-Moderator Guide
Other-Cert. of Confidentiality
Healthcare Professional Ihterviews: Risk Processing for Newly Promoted Prescription Drugs
New
225
0
0
Other-Screener
Other-Moderator Guide
Other-Recruitment Flyer
Healthcare Professional Interviews: Data Disclosures in Communications About Prescription Drugs
New
140
87
0
Other-Email, Screener, and Invitation for Oncologists
Other-Email, Screener, and Invitation for PCPs
Other-Confirmation email
Other-Informed Consents
Other-Reminder email
Other-Interview Guide
Healthcare Professional Interviews: Risk Processing for Newly Promoted Prescription Drugs
New
225
158
0
Other-Screener
Other-Moderator Guide
Other-Consent Forms
Other-Reminder email
Healthcare Professional Interviews: Risk Processing for Newly Promoted Prescription Drugs (CDER)
New
225
0
0
Other-Screener
Other-Informed Consent - nonMedStar
Other-Informed Consent Form - NP and PA
Other-Informed Consent Form - PCP
Other-Informed Consent Form - Specialist
Other-Recruitment Flyer - MedStar
Other-Recruitment Flyer - nonMedStar
Identifying Messages to Promote Value and Education of Generic Prescribing
New
850
213
0
Other-Script
Other-Powerpoint
Other-Post Test
Other-Recruitment Email
Individual Interview Study of Healthcare Provider Perceptions of Boxed Warnings
New
100
60
0
Other-Screener
Other-Moderator Guide
Other-Consent Form for PCP
Other-Consent Form for Specialists
Individual Interview Study of Healthcare Provider Perceptions of Boxed Warnings
New
100
60
0
Other-Screener
Other-Moderator Guide
Other-Consent Form for PCP
Other-Consent Form for Specialists
Naloxone Label Comprehension Questionnaire to Optimize the Drug Facts Label (Task 3 - Adolescents)
New
1120
163
0
Other-Telephone Screener
Other-Interview Guide
Other-Script and Contact Information Sheets
Other-Permission Form
Other-Assent Form
Other-Injector Label
Other-Nasal Label
Naloxone Label Comprehension Questionnaire to Optimize the Drug Facts Label (Task 3 - Adult All Comers)
New
570
498
0
Other-Online Screener
Other-Telephone Screener (Group 1 and 2)
Other-Telephone Screener (Group 4)
Other-Interview Guide (Group 1 and 2)
Other-Interview Guide (Group 4)
Other-Information Sheet (Group 1 and 2)
Other-Study Flyer (Group 1 and 2)
Other-Palm Cards (Group 1 and 2)
Other-Description Table (Group 1 and 2)
Other-Online Advertisement (Group 1 and 2)
Other-Telephone and Email Scripts (Group 1 and 2)
Other-Closing Script (Group 1 and 2)
Other-Closing Script (Group 4)
Other-Consent Form (Group 1,2,&4)
Other-Label - Injector
Other-Label - Nasal
Other-Screenshot - Exhibit 3
Other-Screenshot of Exhibit 4
Other-Certificate of Confidentiality
Physician Interviews on FDA-Approved Labeling
New
330
97
0
Other-Script and Emails
Other-Screener
Other-Confirmation Email
Other-Informed Consent
Other-Interview Guide
Promotional Implications of Proprietary Prescription Drug Names
New
2460
276
0
Other-Survey Instrument
Other-Informed Consent
Rapid Message Testing With Consumer Panel - Asthma Fact Sheet
New
250
21
0
Other-Survey
Other-Interview Guide
Other-Factsheet in English
Other-Factsheet in Spanish
Rapid Message Testing With Consumer Panel - Medical Countermeasure Messages
New
75
18
0
Other-Recruitment Screener
Other-Interview Guide
Other-EUS MCM Message
Other-FDA Approved MCM Message
Other-No MCM Message
Rapid Message Testing with Consumer Panel - BeSafeRx Campaign Messages
New
50
14
0
Other-Participant Screener
Other-Interview Guide
Other-Message Testing
Rapid Message Testing with Consumer Panel - Drug Safety Communications About Misuse and Abuse of Over-the-Counter Medications (CDER)
New
1500
89
0
Other-Interview Guide
Other-Screener
Other-DSC - Benadryl
Other-DSC - Immodium
Other-DSC - Nasadine
Rapid Message Testing with Consumer Panel - FDA's Purple Book Website (CDER)
New
90
16
0
Other-Survey Instrument
Other-Interview Guide
Rapid Message Testing with Consumer Panel - Medication Guide Template for Buprenorphine Products (CDER)
New
100
13
0
Other-Survey Instrument
Other-Moderator Guide
Other-MG Template
Rapid Message Testing with Consumer Panel - Public Service Announcements About Safe Disposal of Opioids
New
250
21
0
Other-Screener
Other-English Interview Guide
Other-Script - English with Alternate Slide 8
Other-Spanish Interview Guide
Other-Script - Spanish with Alternate Slide 5
Other-Script - English with Alternate Slide 5
Rapid Message Testing with Consumer Panel - Retest of Warnings on Opioid Packaging
New
1600
88
0
Other-Interview Guide
Other-Screener
Other-Label - Version 1
Other-Label - Version 2
Rapid Message Testing with Consumer Panel - Safe Drug Disposal Notecard
New
100
16
0
Other-Recruitment Screener
Other-Interview Guide
Other-English Notecard
Other-Spanish Notecard
Rapid Message Testing with Consumer Panel - Storyboards About Safe Disposal of Opioids and Other Medicines
New
96
17
0
Other-Screener
Other-Moderator Guide - English
Other-English - Web Storyboard
Other-English - PSA Storyboard
Other-Moderator Guide - Spanish
Other-Spanish - Web Storyboard
Other-Spanish - PSA Storyboard
Rapid Message Testing with Consumer Panel - Testosterone Medication Guide
New
250
24
0
Other-Survey
Other-Interview Guide
Other-Medication Guide
Rapid Message Testing with Consumer Panel - Transmucosal Immediate Release Fentanyl Patient Presriber Agreement Form
New
400
31
0
Other-Participant Screener
Other-Patient Prescriber Agreement Form
Other-Interview Guide
Rapid Message Testing with Consumer Panel - Vaccines and Seniors Brochure
New
250
20
0
Other-Survey
Other-Consent Form
Other-Brochure
Rapid Message Testing with Consumer Panel - Warnings on Opioid Packaging
New
200
25
0
Other-Screener
Other-Interview Guide
Other-Labels
Rapid Message Testing with Consumer Panel -Messages About Cannabidiol (CBD)
New
75
12
0
Other-CBD messages with context
Other-FDA RAPID CBD Screener
Other-FDA RAPID CBD Interview Guide
Rapid Message Testing with Healthcare Professionals - Search and Rescue Website (CDER)
New
150
20
0
Other-Screener
Other-Interview Guide
Studies to Enhance FDA Communications Addressing Biosimilar Drug Products: Focus Groups and INterviews with Healthcare Professionals
New
316
263
0
Other-Survey Instrument
Other-Consent form - focus groups
Other-Consent form - individual groups
Other-Invitation Email
Other-Appointment confirmation email
Other-Interview guide
Other-Moderator guide
Studies to Enhance FDA Communications Addressing Biosimilar Drug Products: Focus Groups with Patients
New
1000
192
0
Other-Split Web and Phone Screener
Other-Consent Form
Other-Invitation Email
Other-Confirmation Email
Other-Moderator Guide
Other-InterVu Respondent Invitation Template
Studies to Enhance FDA Communications Addressing Biosimilar Drug Products: Patient Focus Groups 2020
New
144
292
0
Other-Advance Email
Other-Invitation
Other-Consent Form
Other-Moderator Guide
Other-Confirmation Script
Other-Screener - Web
Other-Screener - Telephone
Other-Infographic
Other-FDA Facts Article
Total Burden Actually Used for Information Collections Under Currently Approved ICR:
14818
3685
0
Total Burden Currently Requested for Information Collections Under Currently Approved ICR:
0
0
0
To view an IC, click on IC Title